RxDoctor Payments Data

Victoria Statler

Pediatric Infectious Diseases · Louisville, KYNPI 1770604191

Payments from drug & device makers

$403,226in general payments, 2019–2025

Across 176 payments — averaging $2291.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$149K
  • Sanofi Pasteur Inc.$133K
  • Gilead$49K
  • Astellas Pharma Global Development$32K
  • Astellas US Technologies$21K
  • Seqirus USA Inc$9K
  • plus $10K from 2 others
$3,605in research payments, 2019–2025

Across 15 payments — averaging $240.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astellas US Technologies$2K
  • Astellas Pharma Global Development$2K

What the payments were for

  • Consulting fees$5,20832%
  • Speaking & faculty fees$9,03856%
  • Travel & lodging$1,2918%
  • Food & beverage$6304%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Louisville

Where these figures come from

Is this you, or does something look wrong? →